86626-01-9 Usage
Type
Synthetic antineoplastic agent
Uses
Treatment of various types of cancer, including soft tissue sarcoma and ovarian cancer
Mechanism
Binds to the minor groove of DNA, leading to DNA double-strand breaks and cell death
Administration
Intravenous
Common side effects
Nausea, fatigue, and decreased white blood cell count
Precautions
Use only under the guidance of a healthcare professional due to potential for severe side effects and drug interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 86626-01-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,6,2 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 86626-01:
(7*8)+(6*6)+(5*6)+(4*2)+(3*6)+(2*0)+(1*1)=149
149 % 10 = 9
So 86626-01-9 is a valid CAS Registry Number.
86626-01-9Relevant academic research and scientific papers
Preparation of 7-Substituted Pyrrolopyrimidines and 9-Substituted Purines as Potential Antiparasitic Agents
LaMontagne, Maurice P.,Smith, David C.,Wu, Geng-Shuen
, p. 295 - 299 (2007/10/02)
A series of six 7-substituted pyrrolopyrimidines and two 9-substituted purines were prepared and evaluated for potential antiparasitic activity.All were inactive against P. berghei in mice.Six of the target compounds were also evaluated for antitrypanosomal activity against T. rhodensiense in mice.All six compounds were also inactive in this screen.
